GDC--0084, page-28

What some posters do not release and you have to just keep repeating the facts is the Edison report is paid for by KZA, so that shareholders can have clear view what is ahead. Yes a CR will be needed as presented in almost every company presentation for the last year and a half. Honest transparent and proactively telling shareholders exactly what is to come.
What some fail to see are the following historical facts.

1- We needed a CR last year to see as through to the end of 2019, the next big inflection point. Management achieved an all time first for this company in 20 years. A hedge fund Platinum Asset stumped the bulk of the money. They too can read an Edison report but it they can read it with honesty and not dishonest intentions.
That was binary call, as either the data will be good or nonplussed. Thus management took the approach to raise only what was needed to get to that next inflection point.

2- They entered into a Letter of Intent with Cedrus Investments Ltd in china back in 2017 and also have the Shelf Registration Statement on Form F-3 with the US Securities and Exchange Commission for up to 100M USD. My point is these guys are not armatures and have gained the respect of world renowned cancer centres. They have proven to be on their game with dates, timelines, collaborations and don't forget IP disputes.

3 - And yes it getting tiring repeating this line. The data coming from the 28 patients already in the phase II trial will determine what happens. End of story. Why are we so buoyed and happy regardless of the share price. Those collaborations just keep confirming what James was telling us all along. Clinicians are lining up at the door to get a hold of this drug. Forget whatever bullsh&^ spin a CEO may or may not give. Clinicians excited is code for big pharma interest but only after phase II proof. And we are going to have a mini proof study coming out in very soon. And that is beauty of the design around this trials. For shareholder risk is minimised by putting a toe in the water first that will confirm weather we all want to go for a swim and give the necessary data and information for the FDA to approve a fast track registration trial.